TCTAP 2026 Sponsors

Amgen is committed to unlocking the potential of biology to help patients suffering from serious diseases by discovering, developing, manufacturing, and delivering innovative human therapeutics. The company leverages advanced tools such as human genetics to better understand disease biology and identify transformative medicines. At the core of Amgens strategy is the belief that highly differentiated, innovative therapies delivering significant clinical benefits can improve patients lives while reducing the social and economic burden of disease. Founded in 1980, Amgen focuses on areas of high unmet medical need and has grown into one of the worlds leading independent biotechnology companies, reaching millions of patients globally with a robust pipeline of breakthrough medicines.